From: Myofibroblast expression in airways and alveoli is affected by smoking and COPD
Clinical parameters | |||||
---|---|---|---|---|---|
Immunohistochemical findings | Sex* | Pack-years | FEV1/FVC | FEV1 | DLCO |
α-SMA in alveoli | p<0.001 | ρ=−0.295 p=0.006 | ρ=0.426 p<0.001 | ||
α-SMA in bronchioles | ρ=−0.241 p=0.027 | ||||
α-SMA in bronchi | 0.05 | ρ=0.234 p=0.055 | |||
Tn-C in bronchi** | p=0.02 | p<0.001 | |||
EDA-Fn in alveoli | ρ=−0.210 p=0.047 |